U.S. Industrial REITs Stock News

AvalonBay Communities, Inc. recently reported past first-quarter 2026 results showing higher revenue of US$770.28 million and net income of US$325.73 million, issued new EPS guidance for the second quarter and full year 2026, completed US$500 million in share repurchases across two authorizations, and filed a US$40 million ESOP-related common stock shelf registration. This combination of stronger earnings, fresh guidance, and active capital management highlights how AvalonBay is balancing...

In late April 2026, Ford Motor reported first-quarter revenue of US$43,253 million and net income of US$2,548 million, declared a US$0.15 quarterly dividend, and later named Maria Ricciardone as its next chief investor relations officer, effective May 1, 2026. These updates came just as Ford disclosed a 14.4% April US sales decline, especially in electrified vehicles, prompting broad employee-pricing incentives to support demand and raising fresh questions about the balance between volume...

If you are wondering whether ICON's current share price reflects its underlying value, the recent moves in the stock give you a timely reason to take a closer look. The stock recently closed at US$121.32, with returns of 18.4% over 7 days and 6.2% over 30 days, set against a year-to-date return of a 35.7% decline and a 10.2% decline over the past year. These price moves have come as ICON continues to attract attention in the contract research and life sciences outsourcing space, where...

BWX Technologies (BWXT) has just wrapped up Q1 2026 with investors looking closely at how the recent revenue and EPS trajectory sets the tone for the new year, particularly after trailing 12 month net income of US$328.9 million and basic EPS of US$3.59 against a current share price of US$206.15. Over the last six reported quarters, revenue has moved from US$671.9 million in Q3 2024 to US$885.8 million in Q4 2025, while quarterly basic EPS has ranged from US$0.76 to US$1.02, giving investors a...

Cathay General Bancorp reported first-quarter 2026 results, with net interest income rising to US$194.17 million and net income reaching US$86.89 million, alongside higher earnings per share versus a year earlier. On the same day, the company disclosed it had completed a US$150.00 million buyback program and announced a new share repurchase authorization of up to US$150.00 million, underscoring continued capital returns alongside earnings growth. With stronger quarterly earnings and a fresh...

For investors wondering whether Main Street Capital is attractively priced today or if the easier gains are already behind it, this breakdown focuses on what you are paying versus what you may be getting. The stock last closed at US$57.36, with returns of 5.0% over the past week, 9.0% over the past month, a year-to-date decline of 7.1%, and gains of 16.4% over 1 year, 79.7% over 3 years, and 106.8% over 5 years. Recent coverage of Main Street Capital has focused on its position within the...

What Coupang’s Q1 2026 earnings mean for investors Coupang (CPNG) reported Q1 2026 revenue of US$8,504 million and a net loss of US$266 million, a shift from profit a year earlier. This result puts the tradeoff between growth and profitability in focus. See our latest analysis for Coupang. Coupang’s recent Q1 result, together with its US$84 million commitment to AI startups and robotics partnerships, comes after a 9.55% 1 month share price return but a year to date share price return of...

Corebridge Financial (CRBG) opened 2026 earnings season with Q1 results that sit against a recent backdrop where Q4 2025 revenue was about US$6.6b, basic EPS came in at US$1.59, and trailing twelve month EPS was a US$0.68 loss on revenue of roughly US$18.6b. Over the past few quarters, revenue has moved between US$3.2b and US$6.6b while quarterly basic EPS has swung from a loss of US$1.20 to a profit of US$3.81. This underlines how volatile the earnings line has been. For investors, the...

Why MKS Stock Is On Investors’ Radar MKS (MKSI) has been drawing attention after a strong run over the past year, with the stock’s recent price of $287.65 sitting against a backdrop of multi segment semiconductor exposure. See our latest analysis for MKS. The recent pullback in the share price over the last day contrasts with a strong run, with a 30 day share price return of 22.6% and a 1 year total shareholder return of very close to 300%. This suggests that momentum has been building rather...

AdaptHealth (AHCO) has just posted its latest results with Q4 2025 revenue of US$846.3 million and a basic EPS loss of US$0.74, setting the tone for how investors will read the Q1 2026 update. The company has seen quarterly revenue move from US$856.6 million in Q4 2024 to US$846.3 million in Q4 2025, while EPS shifted from US$0.34 to a loss of US$0.74 over the same period. This puts the focus squarely on earnings quality. With the stock trading at US$11.75, investors may pay close attention...

IBM (NYSE:IBM) used its Think 2026 conference to unveil a broad set of enterprise AI and cloud management tools aimed at large organizations. The company introduced IBM Sovereign Core, targeting operational sovereignty and controls for regulated and data sensitive clients. IBM highlighted quantum simulation work with Cleveland Clinic on large protein complexes, focused on biopharma and applied science use cases. The company also announced an expanded industrial AI alliance with Aramco,...

If you are wondering whether Catalyst Pharmaceuticals' recent share price puts it at a bargain or a stretch, the following sections break that question down into clear valuation checks. The stock last closed at US$30.86, with returns of 4.8% over the past week, 25.0% over the past month, 33.3% year to date and 33.8% over the past year, which raises questions about how that performance lines up with underlying value. Recent headlines around Catalyst Pharmaceuticals have focused on its...

Grab Holdings (NasdaqGS:GRAB) has agreed to acquire Delivery Hero’s foodpanda business in Taiwan, marking its first major move beyond Southeast Asia. The deal extends Grab’s delivery footprint into a new market where it has not previously operated. Indonesia has introduced a new regulatory cap on ride hailing commissions, cutting the maximum rate from 20% to 8% and adding new social protections for drivers. These regulatory changes directly affect Grab’s largest regional market and could...

If you are wondering whether BlackSky Technology's current share price reflects its true worth, the recent performance gives plenty to think about. The stock last closed at US$35.96, with returns of 15.2% over 7 days, 16.7% over 30 days, 72.7% year to date, 321.1% over 1 year and 284.2% over 3 years, while the 5 year return sits at a 54.6% decline. Recent price action has drawn attention to BlackSky Technology, with investors focusing on how current expectations align with the stock's past...

Douglas Dynamics (PLOW) opened 2026 with Q1 results that follow a busy 2025, where quarterly revenue ranged from US$115.1 million to US$194.3 million and basic EPS moved between almost flat at US$0.01 and a peak of about US$1.10. Over that period, the company has seen revenue step up from US$143.5 million in Q4 2024 to US$184.5 million in Q4 2025, while basic EPS shifted from US$0.33 to US$0.54, framing a mixed but data rich set of trends for investors to weigh as they assess how margins are...

Danaher (NYSE:DHR) has launched a multi billion euro debt offering. The company plans to use the proceeds primarily to finance its acquisition of Masimo Corporation. The transaction is expected to affect Danaher's capital structure and business mix once completed. Danaher operates across life sciences and diagnostics, so adding Masimo's patient monitoring and medical technology portfolio would further extend its healthcare reach. For investors, the size and currency of the euro debt raise...

BioMarin Pharmaceutical (BMRN) opened 2026 with Q1 results that build on a run of quarterly revenue between US$745.1 million and US$874.6 million over 2025, while EPS has swung from a profit of US$1.25 in Q2 2025 to a loss of US$0.24 in Q4 2025 as one off items fed into the reported figures. Over the last six reported quarters, revenue has ranged from about US$745.1 million to US$874.6 million and trailing 12 month EPS has moved between US$1.70 and US$3.44. This gives you a clear view of how...

Why Cloudflare stock is back in focus Cloudflare (NET) is drawing fresh attention after an independent research firm named it a Leader in edge development platforms, highlighting its vision, roadmap and AI application development capabilities. The company also rolled out Flagship, a feature flag service built into its global edge platform that is designed to support AI generated code patterns. For investors, both developments add context to recent enthusiasm around Cloudflare's role in AI...

Axsome Therapeutics (AXSM) Q1 2026 earnings snapshot Axsome Therapeutics (AXSM) has opened 2026 with Q1 revenue of US$191.2 million and a basic EPS loss of US$1.26, alongside a net loss of US$64.5 million, setting a clear benchmark for how the rest of the year might look. The company has seen revenue progress from US$118.8 million in Q4 2024 to US$191.2 million in Q1 2026, while trailing twelve month EPS has moved from a loss of US$5.99 to a loss of US$3.74 as revenue reached US$708.2 million...

Market snapshot and recent returns Solventum (SOLV) has drawn fresh attention after a period of mixed share performance, with a 2.4% move over the past day and a month gain of 8.6% contrasting with a 9.7% decline over the past 3 months. At a last close of $69.04, the company has a value score of 5 and a market cap of about $11.7b. This has invited closer scrutiny of how its healthcare operations and recent results line up with current pricing. See our latest analysis for Solventum. For...

Event context and recent performance Chefs' Warehouse (CHEF) has attracted attention after recent share price moves, with the stock showing a 1 day return of 1.3%, about 23% over the past week, and around 37% over the past month. See our latest analysis for Chefs' Warehouse. Chefs' Warehouse's recent 1 month share price return of 37.22% sits within a broader upswing, with a year to date share price return of 26.66% and a 1 year total shareholder return of 29.34%, pointing to momentum that has...

Ameresco Q1 2026 earnings in focus Ameresco (AMRC) has come into Q1 2026 with recent quarterly figures that show Q4 2025 revenue at US$581.0 million and basic EPS of US$0.35, alongside trailing twelve month revenue of about US$1.9 billion and basic EPS of US$0.84. The company has seen quarterly revenue move from US$500.9 million in Q3 2024 to US$581.0 million in Q4 2025, while basic EPS over those reported quarters ranged from US$0.24 to US$0.71. This sets up the latest update against a...

In recent days, Tyra Biosciences reported interim Phase 1/2 data for its lead candidate TYRA-300 in metastatic urothelial carcinoma, showing an objective response rate alongside a favorable safety profile. At the same time, the company advanced its bladder cancer pipeline through a new SURF302 trial partnership with the University of Kansas Medical Center, highlighting external confidence in its FGFR3-focused approach. Next, we will examine how TYRA-300’s interim efficacy signal shapes...

Waters (WAT) has just wrapped up its Q1 2026 earnings season backdrop with a recent run of quarterly results that saw Q4 2025 revenue at US$932.4 million and basic EPS of US$3.78, compared with US$872.7 million of revenue and basic EPS of US$3.90 in Q4 2024. Over the past few quarters, revenue has moved from US$740.3 million in Q3 2024 to US$799.9 million in Q3 2025 and US$932.4 million in Q4 2025. Basic EPS has shifted from US$2.72 to US$2.50 and then US$3.78, setting up a results season...